Approvals/CIMA-AEMPS/ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA

Approved

STANDARD

ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA

Glaxosmithkline Biologicals🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 65b67cc8c1edb362
Drug Cima Aemps Name: ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA
Register Number: 05330009IP2
Holder Company Name: Glaxosmithkline Biologicals
Marketing Company Name: Elam Pharma Labs S.L.
Holder Company Detail Path: /organization/glaxosmithkline-biologicals
Authorization Date: 2021-12-15
Dosage Form: SUSPENSIÓN ORAL
Dose: 10 millones de germenes
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline Biologicals
Company Detail Path: /organization/glaxosmithkline-biologicals

ROTAVIRUS HUMANO

10 MILLONES GERMENES

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 15, 2021

Approval ID

65b67cc8c1edb362

Type

Standard